Donation Menu


Donation processes now made easier:

Zakat
You can give your Zakat to help poor cancer patients in their struggle against cancer.

To have your cheque collected directly from your doorstep within Pakistan, Please call 0800 11555.

Donation in Kind

Online Donation


SMS Campaign (In Pakistan)

To help cancer patients, donate Rs. 20 (excluding tax) by sending a blank SMS to 7770 from your cell phone.

PTCL Hope Line (In Pakistan)
To help cancer patients, donate Rs. 14 (excluding tax) by calling 0900-11770 from your PTCL land line.

Greeting Cards
This season you can give a new meaning to your card 

Mobilink Reward Points (In Pakistan)
Call 111 from your Mobilink indigo to donate your Reward Points today.

Askari Bank Credit Card customers can redeem their Reward Points and donate the equivalent rupees worth to needy cancer patients with just one easy phone call to Askari Bank at 0800 00078. 

UBL Netbanking
UBL netbanking customers may transfer funds directly from their account to SKMCH&RC's donation accounts

Blood Donation
Every time you donate blood, someone else can celebrate life

Sponsor a Cancer Patient
Save a life, save mankind

Sponsorship of New Projects
Help SKMCH & RC enhance its capacity to be able to provide treatment facilities to more patients.

Sponsorship of New Equipment
Help SKMCH & RC remain at the cutting edge of technology by providing sponsorships for state-of-the-art equipment.


 


RCPE Symposium on Haematology

Program    |    Transcript

Dear All,

The Royal College of Physicians of Edinburgh (RCPE) organized a symposium on Haematology on Friday, November 4th, 2011. Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH&RC) had this telecasted live. There was no fee for attendance at the SKMCH venue but pre-registration was required especially for outside participants

The event was wel-attended by over 50 attendees including GPs/Family practitioners, Medical residents, Oncology fellows, Medical Oncologists as well as Medical Specialists.



Message from Organizers:

Significant advances have occurred in all aspects of haematology in the last decade. These include a new era for oral anticoagulation therapy with the emergence of the first oral anticoagulants since warfarin over 50 years ago. These agents are likely to change the management of many patients at risk of thrombosis. Meanwhile, improved understanding of disease pathophysiology is being translated into novel targeted therapies for patients with haematological malignancies. These developments, however, occur on the background of an increasingly elderly population and incidence of haematological malignancies. All these exciting new agents are expensive and occur at a time of increasing demand and greater patient complexity.

This one day programme will review the challenges presented by the use of these novel therapeutic approaches and the changing patient demographics; both are likely to have a major impact in primary and secondary care. The emphasis of the day is to provide a frame of reference for the practical application of these new developments.
Presentations are from dynamic and engaging speakers, experts in their field. The programme will be of interest not only to trainees, specialist nurses, and haematologists but those working in primary and secondary care since these new developments are likely to have wide ranging impacts across many areas of patient care.

Dr Fiona M Scott
Chair, Organising Sub Committee